Clinical trial No longer in our active list Interventional Ages 18 to 80 Women only

Exercise program to help with bladder pain syndrome

Official title: Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome

Run by Wake Forest University Health Sciences · NCT05699551 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a guided exercise program can help people with bladder pain syndrome feel better and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexWomen only
Enrollment10 (estimated)
SponsorWake Forest University Health Sciences
Academic / other
Drugs / interventionsradiation, cyclophosphamide
Locations1 site (Winston-Salem, North Carolina)
Trial IDNCT05699551 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult females aged 18 to 80 with a clinical diagnosis of interstitial cystitis/bladder pain syndrome.

Probably not a fit

Patients who are not fully ambulatory or unable to tolerate moderate aerobic exercise may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of a supervised exercise program led by a trained exercise physiologist to alleviate symptoms and improve quality of life for patients suffering from interstitial cystitis/bladder pain syndrome. The research aims to assess not only the physical benefits of exercise on bladder-related symptoms but also its impact on depressive symptoms, which often accompany this condition. Additionally, the study will evaluate urinary markers of inflammation before and after the exercise regimen. This approach seeks to provide a non-invasive, cost-effective therapeutic strategy for managing a challenging condition.

Why it matters

Potential benefit: If successful, this study could provide a new, effective treatment option for patients suffering from interstitial cystitis/bladder pain syndrome.

How similar studies have gone: While the approach of using exercise as a therapeutic strategy for this condition is relatively novel, similar studies in other chronic pain conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult females (\>18 years and \<80 years) with a previously established clinical diagnosis of Interstitial cystitis/bladder pain syndrome (IC/BPS) will be eligible to participate
* Must speak English
* The clinical diagnosis of IC/BPS will be based on the recently published American Urological Association Guidelines definition: "An unpleasant sensation (pain, pressure, or discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms for more than six weeks duration, in the absence of infection or other identifiable causes"
* The diagnosis will be confirmed by a urologist who specializes in the treatment of patients with IC/BPS

Exclusion Criteria:

* Study participants must be fully ambulatory without the use of a cane, walker, or wheelchair
* Study participants must be able to tolerate moderate aerobic exercise. It will also be required that a physician clear any subjects entering the exercise program who have signs and symptoms suggestive of cardiovascular, cerebrovascular, metabolic, or renal disease and have been active 3 days per week for 30 minutes each day
* Any history of bladder cancer, uterine cancer, ovarian cancer, vaginal cancer, the current placement of a catheter, urethral diverticulum, spinal cord injury, stroke, Parkinson's disease, multiple sclerosis, spina bifida, cyclophosphamide treatment, radiation cystitis, bladder tuberculosis, or are experiencing an active genital herpes episode
* Pregnant women are not eligible for this study

Where it's running

  • Wake Forest University Health Sciences
    Winston-Salem, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Stephen J Walker, PhD — Wake Forest University Health Sciences
  • Study coordinator: Stephen J Walker, PhD
  • Email: swalker@wakehealth.edu
  • Phone: 3367493574

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Evaluating a catheter-free method for bladder medication delivery

    This study is testing a new way to deliver bladder medication without a catheter to see if it’s more comfortable and safer for people with conditions like interstitial cystitis and recurrent urinary tract infections.

    Recruiting at 2 sites Jahn Ferenc South Pest Teaching Hospital · Budapest and 1 other locations · NCT06719232

  • Treatment of bladder pain using VNX001

    This study is testing a new treatment called VNX001 to see if it can help people with moderate to severe bladder pain feel better.

    Recruiting at 2 sites Phase 2 Vaneltix Pharma, Inc. · Tucson, Arizona and 4 other locations · NCT06394830

  • Acupuncture for treating bladder pain syndrome in women

    This study is testing if acupuncture, along with some behavior changes, can help women with bladder pain syndrome feel better when other treatments haven't worked.

    Recruiting University Hospitals Cleveland Medical Center · Cleveland, Ohio · NCT06366269

  • Assessing pain types in treating bladder pain syndrome

    This study is trying to see how different types of bladder pain affect how well people with bladder pain syndrome respond to pelvic floor physical therapy and cognitive-behavioral therapy.

    Recruiting Vanderbilt University Medical Center · Franklin, Tennessee · NCT06299683

  • Evaluating VNX001 for bladder pain relief in patients with interstitial cystitis

    This study is testing if a new treatment called VNX001 can help relieve bladder pain in people with interstitial cystitis better than its individual ingredients or a placebo.

    Recruiting at 11 sites Phase 2 Vaneltix Pharma, Inc. · Escondido, California and 13 other locations · NCT05737121

  • PEMF therapy for women with bladder pain syndrome

    This study is testing if a new non-invasive treatment using pulsed electromagnetic fields can help women with bladder pain syndrome feel less pain and improve their urinary symptoms.

    Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT05149573

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.